Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1984 Dec;74(6):2042–2048. doi: 10.1172/JCI111627

Dietary menhaden oil lowers plasma prostaglandins and calcium in mice bearing the prostaglandin-producing HSDM1 fibrosarcoma.

A H Tashjian Jr, E F Voelkel, D R Robinson, L Levine
PMCID: PMC425393  PMID: 6439740

Abstract

The omega 3 class of polyunsaturated fatty acids, particularly eicosapentaenoic acid (EPA, 20:5), has been shown to alter the patterns of arachidonic acid (20:4) metabolism in both in vitro and in vivo systems. To examine further the role of arachidonic acid conversion to prostaglandins (PG) in hypercalcemic mice bearing the PG-producing HSDM1 fibrosarcoma, we have performed experiments in which control and tumor-bearing animals were fed diets either low (0.1-0.2% of total fatty acid) or high (17%) in EPA. In all five experiments performed, tumor-bearing mice eating control diets had markedly elevated (average sixfold above control) plasma concentrations of 13,14-dihydro-15-keto-PGE2 (PGE2-M), while in mice bearing HSDM1 tumors and eating the EPA-enriched menhaden oil diet, the elevation was reduced to only twice control values. The increase in plasma calcium concentration (approximately 2.5 mg/dl above control) in tumor-bearing animals was also reduced significantly (P less than 0.05) to only 1.3 mg/dl above control in mice eating the diet enriched in EPA. Plasma immunoreactive hydroxy fatty acids (i12-HETE) and sulfidopeptide leukotrienes (iSRS) were not elevated in tumor-bearing mice and were unaffected by diet. The contents of PGE2, PGF2 alpha, and 6-keto-PGF1 alpha were lower in tumor tissue from animals eating the diet high in EPA, whereas the tissue contents of i12-HETE and iSRS were not altered by diet. Fatty acid analysis of liver and tumor tissue revealed marked increases in certain omega 3 fatty acids (20:5, 22:5, and 22:6) from animals eating the enriched diet. Body weights, tumor weights, and tumor histology were not significantly altered by diet. To determine whether dietary calcium played a role in the elevation of plasma calcium in mice bearing the HSDM1 tumor and the reduction of plasma calcium in animals fed EPA, we compared results in mice fed diets containing 0.80% (normal) and 0.015% (deficient) calcium. The increases in plasma calcium and PGE2-M observed in tumor-bearing mice were the same on both normal and very low calcium intakes. We conclude, in mice of the Swiss albino strain bearing the HSDM1 fibrosarcoma, that consumption of a diet enriched in EPA reduces the production of cyclooxygenase products of arachidonic acid metabolism and thereby reduces the elevation of plasma calcium concentration. Dietary enrichment with EPA did not alter the production of serologically determined lipoxygenase products of arachidonic acid.

Full text

PDF
2042

Images in this article

2044Image
on p.2044
2045Image
on p.2045
2046Image
on p.2046

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Axelrod L., Levine L. Plasma prostaglandin levels in rats with diabetes mellitus and diabetic ketoacidosis. Diabetes. 1982 Nov;31(11):994–1001. doi: 10.2337/diacare.31.11.994. [DOI] [PubMed] [Google Scholar]
  2. Culp B. R., Titus B. G., Lands W. E. Inhibition of prostaglandin biosynthesis by eicosapentaenoic acid. Prostaglandins Med. 1979 Nov;3(5):269–278. doi: 10.1016/0161-4630(79)90068-5. [DOI] [PubMed] [Google Scholar]
  3. Doppelt S. H., Slovik D. M., Neer R. M., Nolan J., Zusman R. M., Potts J. T., Jr Gut-mediated hypercalcemia in rabbits bearing VX2 carcinoma: new mechanism for tumor-induced hypercalcemia. Proc Natl Acad Sci U S A. 1982 Jan;79(2):640–644. doi: 10.1073/pnas.79.2.640. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Dyerberg J., Bang H. O. Haemostatic function and platelet polyunsaturated fatty acids in Eskimos. Lancet. 1979 Sep 1;2(8140):433–435. doi: 10.1016/s0140-6736(79)91490-9. [DOI] [PubMed] [Google Scholar]
  5. Dyerberg J., Jørgensen K. A. The effect of arachidonic- and eicosapentaenoic acid on the synthesis of prostacyclin-like material in human umbilical vasculature. Artery. 1980;8(1):12–17. [PubMed] [Google Scholar]
  6. Fischer S., Weber P. C. Prostaglandin I3 is formed in vivo in man after dietary eicosapentaenoic acid. Nature. 1984 Jan 12;307(5947):165–168. doi: 10.1038/307165a0. [DOI] [PubMed] [Google Scholar]
  7. Gaudet R. J., Alam I., Levine L. Accumulation of cyclooxygenase products of arachidonic acid metabolism in gerbil brain during reperfusion after bilateral common carotid artery occlusion. J Neurochem. 1980 Sep;35(3):653–658. doi: 10.1111/j.1471-4159.1980.tb03704.x. [DOI] [PubMed] [Google Scholar]
  8. Hamazaki T., Hirai A., Terano T., Sajiki J., Kondo S., Fujita T., Tamura Y., Kumagai A. Effects of orally administered ethyl ester of eicosapentaenoic acid (EPA; C20:5, omega-3) on PGI2-like substance production by rat aorta. Prostaglandins. 1982 Apr;23(4):557–567. doi: 10.1016/0090-6980(82)90116-2. [DOI] [PubMed] [Google Scholar]
  9. Hornstra G., Christ-Hazelhof E., Haddeman E., ten Hoor F., Nugteren D. H. Fish oil feeding lowers thromboxane- and prostacyclin production by rat platelets and aorta and does not result in the formation of prostaglandin I3. Prostaglandins. 1981 May;21(5):727–738. doi: 10.1016/0090-6980(81)90230-6. [DOI] [PubMed] [Google Scholar]
  10. KENNY A. D., MUNSON P. L. A method for the biological assay of phosphaturic activity in parathyroid extracts. Endocrinology. 1959 Apr;64(4):513–521. doi: 10.1210/endo-64-4-513. [DOI] [PubMed] [Google Scholar]
  11. Lands W. E., Byrnes M. J. The influence of ambient peroxides on the conversion of 5,8,11,14,17-eicosapentaenoic acid to prostaglandins. Prog Lipid Res. 1981;20:287–290. doi: 10.1016/0163-7827(81)90057-6. [DOI] [PubMed] [Google Scholar]
  12. Leitch A. G., Lee T. H., Ringel E. W., Prickett J. D., Robinson D. R., Pyne S. G., Corey E. J., Drazen J. M., Austen K. F., Lewis R. A. Immunologically induced generation of tetraene and pentaene leukotrienes in the peritoneal cavities of menhaden-fed rats. J Immunol. 1984 May;132(5):2559–2565. [PubMed] [Google Scholar]
  13. Levine L., Alam I. Arachidonic acid metabolism by cells in culture: analyses of culture fluids for cyclooxygenase products by radioimmunoassay before and after separation by high pressure liquid chromatography. Prostaglandins Med. 1979 Nov;3(5):295–304. doi: 10.1016/0161-4630(79)90071-5. [DOI] [PubMed] [Google Scholar]
  14. Levine L., Hinkle P. M., Voelkel E. F., Tashjian A. H., Jr Prostaglandin production by mouse fibrosarcoma cells in culture: inhibition by indomethacin and aspirin. Biochem Biophys Res Commun. 1972 May 26;47(4):888–896. doi: 10.1016/0006-291x(72)90576-1. [DOI] [PubMed] [Google Scholar]
  15. Levine L., Morgan R. A., Lewis R. A., Austen K. F., Clark D. A., Marfat A., Corey E. J. Radioimmunoassay of the leukotrienes of slow reacting substance of anaphylaxis. Proc Natl Acad Sci U S A. 1981 Dec;78(12):7692–7696. doi: 10.1073/pnas.78.12.7692. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Lockette W. E., Webb R. C., Culp B. R., Pitt B. Vascular reactivity and high dietary eicosapentaenoic acid. Prostaglandins. 1982 Nov;24(5):631–639. doi: 10.1016/0090-6980(82)90033-8. [DOI] [PubMed] [Google Scholar]
  17. Morita I., Saito Y., Chang W. C., Murota S. Effects of purified eicosapentaenoic acid on arachidonic acid metabolism in cultured murine aortic smooth muscle cells, vessel walls and platelets. Lipids. 1983 Jan;18(1):42–49. doi: 10.1007/BF02534689. [DOI] [PubMed] [Google Scholar]
  18. Murphy R. C., Pickett W. C., Culp B. R., Lands W. E. Tetraene and pentaene leukotrienes: selective production from murine mastocytoma cells after dietary manipulation. Prostaglandins. 1981 Oct;22(4):613–622. doi: 10.1016/0090-6980(81)90070-8. [DOI] [PubMed] [Google Scholar]
  19. Rigas B., Lewis R. A., Austen K. F., Corey E. J., Levine L. Identification and quantitation of arachidonic-acid metabolic products in rabbit, rat and human saliva. Arch Oral Biol. 1983;28(11):1031–1035. doi: 10.1016/0003-9969(83)90058-4. [DOI] [PubMed] [Google Scholar]
  20. Schelling S. H., Wolfe H. J., Tashjian A. H., Jr Role of the osteoclast in prostaglandin E2-stimulated bone resorption: a correlative morphometric and biochemical analysis. Lab Invest. 1980 Mar;42(3):290–295. [PubMed] [Google Scholar]
  21. Socini A., Galli C., Colombo C., Tremoli E. Fish oil administration as a supplement to a corn oil containing diet affects arterial prostacyclin production more than platelet thromboxane formation in the rat. Prostaglandins. 1983 May;25(5):693–710. doi: 10.1016/0090-6980(83)90123-5. [DOI] [PubMed] [Google Scholar]
  22. Spector A. A., Kaduce T. L., Figard P. H., Norton K. C., Hoak J. C., Czervionke R. L. Eicosapentaenoic acid and prostacyclin production by cultured human endothelial cells. J Lipid Res. 1983 Dec;24(12):1595–1604. [PubMed] [Google Scholar]
  23. Tashjian A. H., Jr, Levine L. Epidermal growth factor stimulates prostaglandin production and bone resorption in cultured mouse calvaria. Biochem Biophys Res Commun. 1978 Dec 14;85(3):966–975. doi: 10.1016/0006-291x(78)90638-1. [DOI] [PubMed] [Google Scholar]
  24. Tashjian A. H., Jr, Tice J. E., Sides K. Biological activities of prostaglandin analogues and metabolites on bone in organ culture. Nature. 1977 Apr 14;266(5603):645–647. doi: 10.1038/266645a0. [DOI] [PubMed] [Google Scholar]
  25. Tashjian A. H., Jr, Voelkel E. F., Goldhaber P., Levine L. Prostaglandins, calcium metabolism and cancer. Fed Proc. 1974 Jan;33(1):81–86. [PubMed] [Google Scholar]
  26. Tashjian A. H., Jr, Voelkel E. F., Goldhaber P., Levine L. Successful treatment of hypercalcemia by indomethacin in mice bearing a prostaglandin-producing fibrosarcoma. Prostaglandins. 1973 Apr;3(4):515–524. doi: 10.1016/0090-6980(73)90161-5. [DOI] [PubMed] [Google Scholar]
  27. Tashjian A. H., Jr, Voelkel E. F., Levine L. Effects of hydrocortisone on the hypercalcemia and plasma levels of 13,14-dihydro-15-keto-prostaglandin E2 in mice bearing the HSDM1 fibrosarcoma. Biochem Biophys Res Commun. 1977 Jan 10;74(1):199–207. doi: 10.1016/0006-291x(77)91394-8. [DOI] [PubMed] [Google Scholar]
  28. Tashjian A. H., Jr, Voelkel E. F., Levine L., Goldhaber P. Evidence that the bone resorption-stimulating factor produced by mouse fibrosarcoma cells is prostaglandin E 2 . A new model for the hypercalcemia of cancer. J Exp Med. 1972 Dec 1;136(6):1329–1343. doi: 10.1084/jem.136.6.1329. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Tashjian A. H., Jr, Voelkel E. F., McDonough J., Levine L. Hydrocortisone inhibits prostaglandin production by mouse fibrosarcoma cells. Nature. 1975 Dec 25;258(5537):739–741. doi: 10.1038/258739a0. [DOI] [PubMed] [Google Scholar]
  30. Voelkel E. F., Tashjian A. H., Jr, Levine L. Cyclooxygenase products of arachidonic acid metabolism by mouse bone in organ culture. Biochim Biophys Acta. 1980 Dec 5;620(3):418–428. doi: 10.1016/0005-2760(80)90133-2. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES